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ABSTRACT: Protein translocation in Escherichia coli is mediated by the SecA ATPase bound to the SecYEG
membrane protein complex. SecA translocation ATPase activity as well as protein translocation is
dependent on the presence of negatively charged lipids. By using a phospholipid with an acyl chain
linked photoactivatable group, the lipid accessibility of SecA bound at the translocase was explored. SecA
bound to lipid vesicles containing negatively charged lipids was found to be readily accessible for labeling
by the photoactivatable phospholipid. The presence of an excess amount of SecYEG complex resulted
in a remarkable reduction in the amount of lipid-accessible SecA irrespective of the nucleotide-bound
form of SecA. These data demonstrate that the SecYEG-bound SecA is largely shielded from the
phospholipid acyl chains and suggest the presence of two distinct pools of membrane-bound SecA that
differ in the degree of lipid association.
In Escherichia coli, proteins functioning outside the cytosol
are transported across the inner membrane from the site of
synthesis to their site of catalysis. Most of the proteins
involved in this process, that is, components of the secretion
machinery, have been identified by genetic analysis (1, 2).
Biochemical approaches are now successfully used to obtain
more insight into the molecular mechanisms by which the
secretion machinery acts.
Proteins destined for secretion contain an N-terminal signal
sequence that is recognized by the secretion machinery,
termed precursor protein translocase. Translocase consists
of the soluble component SecB, the integral membrane
protein complexes SecYEG and SecDFYajC (3), and SecA
that is present in the cytosol and bound to the membrane
(4). SecY, together with SecE and SecG, forms the
translocation channel. SecDFYajC may only be transiently
associated with the translocase. The energy required for the
translocation process is derived from ATP hydrolysis by
SecA and from the proton motive force (pmf)1 (5). During
or directly after translocation, the signal sequence is removed
by leader peptidase.
Its ability to convert chemical energy into net movement
of the precursor protein makes SecA the key component of
the translocase. SecA is bound to the membrane with low
affinity, presumably to the phospholipids, and to sites
consisting of SecYEG with high affinity (6, 7). SecA is a
102-kDa protein with two ATP binding sites (8) and is active
as a dimer (9). Each monomer consists of two large domains
that interact with each other in a nucleotide-dependent
manner (10). SecA recognizes the signal sequence of
proteins destined for secretion, and when bound at the
membrane, SecA drives translocation by binding and hy-
drolyzing ATP, thereby cycling through a series of confor-
mational states. In the presence of ATP and precursor
protein, SecA is thought to insert into the membrane and
two domains of 30 and 65 kDa become protease-inaccessible
(11, 12). Upon hydrolysis of ATP, SecA de-inserts from
the membrane. In each cycle 20-30 amino acid residues
of the precursor protein are moved across the membrane (13).
Both the N- and C-terminal domains are accessible for
modifying reagents from the periplasmic side of the mem-
brane (14-16). The C-terminal domain is even accessible
for protease digestion from the periplasmic side of the
membrane (16).
SecB, used by a subset of precursor proteins as a targeting
device (17), recognizes the unfolded precursor and subse-
quently binds to the C-terminus of SecA (18) at the
membrane (6). Furthermore, SecB keeps precursor proteins
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in a translocation competent state by preventing aggregation
and stable folding (19-21). Insertion of SecA is ac-
companied by the release of SecB into the cytosol (22) and
a complete topological inversion of SecG (23). Association
of the SecDFYajC complex with SecYEG leads to stabiliza-
tion of SecA in the inserted state (24).
Besides the precursor protein translocase, phospholipids
also play an important role in translocation. The major
phospholipids in the E. coli inner membrane are 75-80%
phosphatidylethanolamine (PE), 20% phosphatidylglycerol
(PG), and 1-5% cardiolipin (25). PE has a high propensity
to form nonbilayer structures, and this property is important
for protein translocation (26). Negatively charged phospho-
lipids are needed for efficient translocation. Strains contain-
ing lower levels of PG and cardiolipin are impaired in protein
translocation (27). Negatively charged lipids may be needed
at various stages of translocation. The ability of signal
sequences to insert into model membranes strongly correlates
with their in vivo function (28, 29). Negatively charged
lipids induce R-helix formation of the signal sequence (30)
and are thought to directly interact with positive charges of
the signal sequence (31). Overexpression of phosphatidyl-
glycerophosphate synthase suppresses a secG deletion, sug-
gesting a role for negatively charged phospholipids in the
SecG function (32). SecA penetrates deeply into model
membranes (33) up to the center of the phospholipid bilayer
(34). Insertion into lipid monolayers is strongly dependent
on negatively charged phospholipids and inhibited by ATP
(35). SecA lipid ATPase activity and SecA translocation
ATPase activity are stimulated by negatively charged lipids
(36). Reduction of the negatively charged phospholipid
content in the membrane results in higher expression levels
and an altered cellular distribution of SecA (37). These data
suggest an important role for SecA lipid interactions during
protein translocation.
An important question is whether SecA inserts in the
membrane via a lipid environment or through a proteinaceous
pore formed by the SecYEG complex. The proteolytic 30-
kDa domain of SecA has recently been found not to be
accessible for photolabeling from the hydrophobic region of
the membrane with a lipid-soluble marker (38). Reconstitu-
tion of SecYEG with a photoactivatable phospholipid
analogue provides a system to study SecA lipid interactions
without the need of a protease resistance assay. We used
this system to answer the question whether SecA at the site
of translocation is in direct contact with phospholipids. SecA
insertion into the phospholipid bilayer was found to be
dependent on the presence of negatively charged phospho-
lipids. However, SecA bound at the translocase was largely
shielded from the hydrophobic region of the bilayer. This
suggests that the negatively charged phospholipids do not
play their role via direct interactions with SecA at the
translocase. A possible role for the lipid-bound SecA will
be discussed.
EXPERIMENTAL PROCEDURES
Materials. SecA (39), SecB (21), and proOmpA (40) were
prepared as described. The prePhoE signal-sequence mutant
G-10C was expressed from pNN102, which consists of the
PacI-BglII fragment from pNN7 (41) cloned in pNN100. The
prePhoE mutant K125C containing the wild-type signal
sequence was expressed from pNN105 which was con-
structed by changing the lysine codon 125 of PhoE on pJP29
(42) into a cysteine codon as described (41) resulting in
pMS37. Subsequently, the PacI-BglII fragment of pMS37
was cloned into pNN100. PrePhoE mutants were purified
as described (20). Protein concentrations were determined
with Bradford analysis using BSA as standard (43). SecYEG
complex was purified from a SecYEG overproducing strain
(16) as described (44). ATP, AMP-PNP, and DTT were
from Sigma Chemical Co. (St. Louis, MO). ADP, ATPçS,
ampicilin, phospholipase D (type I from cabbage), and
proteinase K were from Boehringer (Mannheim, Germany).
“Reactivials” were from Pierce (Rockford, IL), Na125I (350-
600 mCi/mL in NaOH) and 14C-labeled protein markers were
from Amersham (Buckinghamshire, UK). DOPC and DOPG
were from Avanti Polar Lipids (Alabaster, AL). E. coli
phospholipids were isolated from strain MC4100 as described
(45). Radiolabeling of precursor proteins was done as
described (16). All other chemicals were analytical grade
or better.
Preparation of Radioiodinated Photoprobes. The photo-
activatable phospholipid [125I]TID-PC (Figure 1) was pre-
pared by radioiododestannylation of the tin-based precursor
TTD-PC (46). All steps were done at room temperature
under normal laboratory fluorescent light. Briefly, 50 nmol
of TTD-PC was dried in a 1-mL “reactivial” under a stream
of nitrogen. The dried material was redissolved in 20 íL
of acetic acid to which 5 mCi of Na125I was added. The
reaction was started by the addition of 10 íL of a 32% (w/
v) peracetic acid solution in acetic acid. After 2 min, 5 íL
of 100 mM NaI was added to convert all remaining TTD-
PC into [125I]TID-PC. After another 2-min incubation, the
reaction was quenched by addition of 100 íL of 10% (w/v)
Na2S2O5. Then, 100 íL of chloroform/methanol (2:1 v/v)
was added, and after vortexing, the lower organic phase was
collected. This extraction step was repeated twice. The
organic solvent was dried, and the radioiodinated lipid was
dissolved in chloroform/methanol/water (65:25:4, v/v/v). The
material was eluted on a silica gel column (5 g of silica)
with chloroform/methanol/water (65:25:4, v/v/v). Fractions
were collected and analyzed by TLC (same solvent) and
autoradiography. [125I]TID-PC-containing fractions were
collected, dried, and dissolved in toluene/ethanol (1:1, v/v).
Radioiodination efficiencies of 60-80% were routinely
obtained.
[125I]TID-PC was converted into the respective phosphati-
dylglycerol analogue [125I]TID-PG by phospholipase D
mediated headgroup exchange (47). Shortly, [125I]TID-PC
(200 íCi) was dried and dissolved in 200 íL of diethyl ether.
Then 200 íL of 100 mM NaAc pH 5.6, 40 mM CaCl2, and
50% glycerol containing 30 units of phospholipase D was
added. The solution was stirred rigorously for 20 min at 30
°C. Lipid material was extracted as described above,
separated by TLC with chloroform/methanol/water (65:25:
4, v/v/v), and analyzed with autoradiography. The radioac-
FIGURE 1: The structure of [125I]TID-PC.
12262 Biochemistry, Vol. 37, No. 35, 1998 van Voorst et al.
tive spot containing [125I]TID-PG was scraped off and eluted
with chloroform/methanol (1:1, v/v). Phospholipid was
analyzed on TLC as above. [125I]TID-PG was found to be
more than 99% pure. The total yield of the reaction was
7%.
Preparation of LUVs. Radioactive phospholipid (50 íCi)
was added to 1.25 ímol of phospholipid in chloroform.
Lipids were dried under nitrogen and placed under high
vacuum for 1 h. Lipids were hydrated in 1 mL of 50 mM
Tris/HCl, pH 7.9, and 50 mM KCl and freeze-thawed 5
times. The resulting multilamellar vesicles were extruded
through a polycarbonate filter with a 200-nm pore size by
applying a nitrogen pressure of 0.5 MPa to obtain large
unilamellar vesicles (LUVs) (48).
Cross-Linking Reactions. For cross-linking reactions,
samples were photolyzed by a 15-W UV light source
(CAMAC universal lamp) at 366 nm for 5 min at a 1-cm
distance. The half-life of the photoreactive group under these
conditions was found to be less than 1 min, as determined
by the decay of the diazirine characteristic absorption at 351
nm (46).
Determination of Penetration of SecA in Phospholipid
Bilayers. SecA (100 íg), LUVs (60 nmol of Pi) composed
of DOPC/DOPG 1:1 (mol/mol) containing [125I]TID-PC, and
various nucleotides (4 mM) were incubated in buffer (50
mM Tris/HCl, pH 7.6, 100 mM KCl, 4 mM MgCl2) for 10
min at room temperature. Vesicles with bound SecA were
pelleted at 70 krpm for 30 min in a Beckman TLA 100.3
rotor. Pellet and supernatant fractions were separated and
photolyzed. Proteins were precipitated by TCA and dis-
solved in 3% SDS, 6 M urea, and 50 mM Tris/HCl, pH 7.6.
Protein concentration in the samples was determined with
the BCA method (10% of the sample). Radioactive labeling
was analyzed after separation on 7.5% SDS-PAGE by
ç-counting of the excised coomassie stained bands (80% of
the sample). From these data the specific radioactivity (cpm/
íg of protein) was calculated.
Reconstitution of SecYEG into Proteoliposomes. The
SecYEG (200 íL) complex in mixed micellar solution
(0.25-0.5 mg of protein/mL) with 1.25% (w/v) n-octyl-â-
D-glucopyranoside (OG), 10 mM Tris/HCl, pH 8.0, 40%
glycerol, 100 mM KCl, and 0.5 mg/mL E. coli phospholipids
was mixed with 2 íL of a dispersion of sonicated E. coli
phospholipids (50 mg/mL in 1 mM DTT) and [125I]TID-PC
(100 íCi, 1-3 nmol). Proteoliposomes were formed by
dilution with 9 mL of 50 mM Tris/HCl, pH 7.9, 50 mM
KCl, and 1 mM DTT and incubated overnight on ice.
Proteoliposomes were collected by ultracentrifugation for 1
h at 45 krpm (Beckman TY65 rotor), resuspended in 200
íL of 50 mM Tris, pH 7.9, 50 mM KCl, and 1 mM DTT,
and assayed for translocation ATPase activity (36). Lipo-
somes were prepared in the same way by diluting 200 íg of
E. coli lipids from a 1.25% OG solution.
Translocation Assays. Reaction mixtures (50 íL) con-
tained SecA (20 íg/mL), SecB (34 íg/mL), ATP (2 mM),
and proteoliposomes (5 íL) in translocation buffer (50 mM
HEPES/KOH, pH 7.9, 30 mM KCl, 2 mM DTT, 20 mM
MgAc). Precursor proteins were diluted 50-fold from a
solution containing 6 M urea and 50 mM Tris/HCl, pH 7.9,
and incubated in the reaction mixture at 37 °C for 20 min.
Forty-five microliters of the reaction mixture was added to
1 íL of proteinase K (5 mg/mL) and incubated for 10 min
on ice. Reactions were stopped by the addition of an equal
volume of 20% (w/v) TCA. Samples were centrifuged for
10 min at 13 krpm in an Eppendorf centrifuge, washed with
acetone, and analyzed on 15% SDS-PAGE (49).
Other Methods. BCA protein determination was done
using a micro BCA reagent kit according to manufacturer
instructions (Pierce, Rockford, IL). Phospholipid concentra-
tions were determined as described (50). ç-Counting was
done with a Packard crystal multidetector RIA system.
RESULTS
NegatiVely Charged Phospholipids Are Essential for
Insertion of SecA into the Hydrophobic Region of the Bilayer.
SecA insertion into phospholipid bi- and monolayers has
been shown by various methods (33-35). To demonstrate
that [125I]TID-PC is a suitable probe for measuring the bilayer
insertion of SecA, SecA was photolabeled in the presence
of LUVs containing the radiolabeled phospholipid analogue
(Figure 1). Upon incubation of SecA with LUVs composed
of E. coli phospholipids and subsequent photolysis of the
probe, SecA becomes radioactively labeled. Parts A and B
of Figure 2 show an autoradiogram of a typical photo-cross-
link experiment and the results of a quantitative analysis,
respectively. SecA in the nonphotolyzed samples shows only
a low level of labeling. In the presence of LUVs of DOPC
very little labeling was obtained, consistent with previous
observations showing that this lipid does not support SecA
membrane insertion (35). This also demonstrates that the
probe is restricted to the bilayer. The labeling efficiency
increased with the amount of negatively charged phospho-
lipid in the membrane and was maximal with pure DOPG
LUVs. When instead of [125I]TID-PC, [125I]TID-PG was
used as probe with DOPC/DOPG (1:1) LUVs, a similar
labeling efficiency was obtained (data not shown). This
demonstrates that the photoreactivatable PC and PG lipid
analogues report the SecA membrane insertion similarly.
When an increasing amount of SecA was added to DOPC/
DOPG (1:1) LUVs, the amount of labeling increased,
saturating at about 250 lipid molecules/added SecA monomer
(Figure 2C). This value is in agreement with the stoichi-
ometry of the SecA lipid interaction that was obtained
previously (51). Labeling efficiencies at room temperature
or at 37 °C were comparable (data not shown). On the basis
of these results it is concluded that [125I]TID-PC is a suitable
probe for determining the insertion of SecA into phospholipid
bilayers.
The interaction of SecA with phospholipids was reported
to depend on the presence of nucleotides (34, 35). To
investigate whether the extent of membrane penetration is
nucleotide-dependent, SecA was incubated with [125I]TID-
PC-containing LUVs composed of DOPC/DOPG (1:1) in the
presence and absence of nucleotides. The vesicles were
collected by centrifugation, and samples were photolyzed.
In the absence of LUVs no SecA was pelleted. The specific
radioactivity of the bound and labeled SecA was determined
(Figure 3). Under all conditions SecA was labeled with equal
efficiency. Also, variation of the phospholipid composition
(pure DOPG, E. coli phospholipids) or the use of [125I]TID-
PG instead of [125I]TID-PC also showed an equal labeling
efficiency in the presence of different nucleotides (data not
shown). It was reported previously that addition of SecA
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to DOPG LUVs results in vesicle aggregation which is
inhibited by ATP (51). This aggregation is mediated by the
simultaneous interaction of a C-terminal electrostatic lipid-
binding site and a hydrophobic lipid-binding site close to
the N-terminus with two different vesicles. Under conditions
where the nucleotide-dependent aggregation of nonradioac-
tive vesicles was observed (not shown), we did not observe
a nucleotide dependency of labeling in the presence of [125I]-
TID-PC-containing vesicles. This demonstrates that in our
system the interaction of SecA with lipids is modulated by
nucleotides as reported previously but the degree of exposure
to the phospholipid acyl chains is not. Efficient labeling of
SecA is also observed at high ionic strength (500 mM KCl)
irrespective of the nucleotide present, indicating that the
electrostatic binding site is not involved in photolabeling.
Proteoliposomes with Reconstituted SecYEG Containing
[125I]TID-PC Support Protein Translocation. Reconstitution
of SecYEG into proteoliposomes provides a simple system
to incorporate [125I]TID-PC into membranes that support
protein translocation. Proteoliposomes were prepared by
rapid dilution of the octylglucoside-solubilized purified
SecYEG in the presence of E. coli phospholipids and
unlabeled TID-PC (2% of total phospholipid content). The
latter is 2-10 times more than the amount of radioiodinated
[125I]TID-PC used in photolabeling experiments. These
proteoliposomes showed a translocation ATPase activity of
120 pmol of Pi/(min íL), which is comparable to the activity
found in the absence of TID-PC. Proteoliposomes were
active in the translocation of different precursor proteins
(Figure 4). ProOmpA and a prePhoE translocate in an ATP-
and SecA-dependent manner with efficiencies of 48% and
6.5%, respectively. Interestingly, the translocation of pre-
PhoE with a glycine to cysteine mutation in the hydrophobic
core of the signal sequence was three times more efficient
than with the wild-type signal sequence (i.e., 22% instead
of 6.5%). This mutation was reported to result in a lower
pmf dependency for translocation (41), and therefore, trans-
location in these pmf-deficient proteoliposomes is increased.
It is, therefore, concluded that the TID-PC-containing Sec-
YEG proteoliposomes are a genuine tool to analyze the SecA
phospholipid interaction under translocation conditions.
A Fraction of SecA Is in Contact with Phospholipids
during Protein Translocation. To investigate whether SecA
FIGURE 2: SecA inserts into the hydrophobic region of LUVs
containing negatively charged phospholipids. (A) LUVs containing
[125I]TID-PC were prepared from E. coli phospholipids, DOPG,
DOPG/DOPC (1:1), and DOPC. SecA (10 íg), ATP (2 mM), and
LUVs (12.5 nmol of phospholipid) were incubated in translocation
buffer at 37 °C. After 10 min, cross-link reactions were performed
as described in Materials and Methods. (B) The amount of
radioactivity is depicted as a percentage of the highest value
obtained. (C) Increasing amounts of SecA were labeled in the
presence of DOPC/DOPG (1:1) LUVs (20 íg).
FIGURE 3: SecA labeling is not modulated by different nucleotides.
SecA membrane penetration was determined as described in
Materials and Methods for the nucleotides shown.
FIGURE 4: Vesicles containing [125I]TID-PC support translocation
of proOmpA and prePhoE. Translocation reactions were performed,
using [125I]-labeled proOmpA, prePhoE, and prePhoE G-10C as
described in Materials and Methods. For each precursor was used
a 10% standard (10% st) and a reaction with (+ATP) and without
(-ATP) ATP is shown.
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is in contact with phospholipids, SecA (same amount [20
íg/mL] as used in translocation reactions) was incubated with
SecYEG proteoliposomes containing [125I]TID-PC in the
presence of ATP and proOmpA. After 10 min of incubation
at 37 °C, the samples were photolyzed. This resulted in
labeling of SecA (Figure 5). Furthermore, a band corre-
sponding to SecY and a band corresponding to SecE and
SecG, which do not run separately under these conditions,
were also labeled. Bands running below SecEG are unrelated
to protein since these also appear when liposomes prepared
by octylglucoside dilution are photolyzed. In some experi-
ments proOmpA was also visible as a labeled band (data
not shown). Labeling of SecB was never observed, dem-
onstrating that also in proteoliposomes the [125I]TID-PC
probe is restricted to the hydrophobic region of the mem-
brane. Labeling of SecA was not dependent on the presence
of proOmpA or ATP (Figure 5), as evident from the
quantitation of the SecA labeling on autoradiograms of
several independent experiments. Also, addition of the
nonhydrolyzable nucleotides AMP-PNP and ATPçS did not
change the labeling efficiency of SecA (data not shown).
Therefore, it is concluded that under these conditions a
fraction of the SecA is in contact with the phospholipids.
SecA at the Translocase Is Largely Shielded from the
Phospholipids. SecA labeled in the presence of proteolipo-
somes can be derived from lipid-bound SecA or from SecA
bound to the SecYEG complex. To determine the relative
lipid accessibility of SecA in each of these topologies, SecA
labeling in the presence of liposomes was quantitatively
compared to the labeling in the presence of SecYEG
proteoliposomes. This experiment was performed in the
presence of proOmpA and ATP, conditions that lead to
stabilization of the membrane-inserted state of SecA (11).
Liposomes and the SecYEG proteoliposomes contained
identical amounts of lipids and label. When SecA was
incubated with increasing amounts of liposomes, the SecA
labeling also increased (Figure 6, parts A and B). This
reflects an increase in binding of SecA to the liposomes
(compare Figure 2C). In striking contrast, titration with
increasing amounts of SecYEG proteoliposomes did not
result in a significant increase of the amount of SecA labeled.
At the highest point SecA labeling in the proteoliposomes
is only 8% of the labeling in the presence of liposomes. The
increase in SecY labeling (Figure 6A) is a result of the
increased amounts of SecY. SecA binds with high affinity
to SecYEG binding sites at the membrane (6). In proteo-
liposomes the binding of SecA to SecYEG can be monitored
by protection of a His-tag against cleavage by enterokinase
(44). Protection is maximal when the SecA monomer is
present in slight excess relative to SecYEG (44). This
indicates that SecA binds SecYEG with high affinity in the
reconstituted system. Furthermore, this binding is functional
as it correlates to the translocation ATPase and translocation
activity of the proteoliposomes. Given the stoichiometries
FIGURE 5: SecA is labeled under translocation conditions. Trans-
location reactions were performed as described. After 10 min at
37 °C, samples were photolyzed, and CHCl3/MeOH was precipi-
tated and analyzed by 15% SDS-PAGE and phosphorimaging. In
lane 2 proOmpA was omitted from the reaction, in lane 3 ATP
was omitted, and in lane 4 both were omitted. The positions of
molecular weight markers are indicated.
FIGURE 6: SecA is shielded from the phospholipids in SecYEG-
containing vesicles. (A) To reaction mixtures containing SecA,
proOmpA, ATP, and translocation buffer, increasing amounts of
liposomes or proteoliposomes were added. After 20 min of
incubation at 37 °C, samples were photolyzed and analyzed as
described. (B) Quantitative analysis of the SecA labeled in the
presence of liposomes (squares) or proteoliposomes (diamonds).
The molar ratio of SecYEG over the SecA dimer is indicated (only
applicable to the SecYEG-containing vesicles). This figure takes
into account that only half of the SecYEG complexes are oriented
correctly. The molar ratio of phospholipid over the SecA dimer is
indicated and applies to both types of vesicles.
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of this experiment (Figure 6A) ranging from 1.5 to 25
SecYEG heterotrimers/SecA dimer, most of the SecA will
be bound to the SecYEG complex which is present in excess.
This low amount of labeling compared to the labeling
observed in the presence of liposomes combined with the
knowledge that the amount of SecA bound to the SecYEG
proteoliposomes is maximal lead to the conclusion that SecA
bound at the translocase has at least a 10-fold lower access
to the acyl chains than lipid-bound SecA.
The experiment described above was performed under
conditions that lead to formation of the membrane-inserted
state (11, 44). Binding to the translocase does not require
nucleotides or precursor proteins (44). To investigate the
lipid accessibility of SecA bound at the translocase under
various conditions, SecA was incubated with an excess of
SecYEG proteoliposomes (Figure 7), and either the precursor
protein proOmpA or ATP or both were omitted. Under none
of these conditions was SecA accessible from the lipid
bilayer. Also in the presence of AMP-PNP or azide, two
agents that block SecA in the membrane inserted state (11,
52), SecA was largely shielded from the label in the
phospholipid bilayer. To exclude that SecY inhibits SecA
labeling in these vesicles per se, the amount of SecA was
increased to allow binding to the phospholipids. Under these
conditions labeling of SecA does occur (lanes 7 and 8). These
results let us conclude that SecA bound to the SecYEG
complex is largely shielded from the hydrophobic region of
the membrane independent of its SecYEG-bound conforma-
tion.
DISCUSSION
In this study the insertion of SecA in the lipid bilayer in
the absence and presence of the SecYEG complex was
studied with a cross-linking approach using the photoacti-
vatable phospholipid analogues [125I]TID-PC and [125I]TID-
PG. Efficient labeling was observed when SecA was
incubated with vesicles prepared from E. coli phospholipids.
Labeling was dependent on the presence of negatively
charged lipids. With pure DOPC vesicles no labeling was
observed. Previous experiments revealed that SecA is able
to insert into a DOPG monolayer, but not into a DOPC
monolayer at a surface pressure comparable to that in a
phospholipid bilayer (35, 53). These findings indicate that
labeling directly correlates with membrane insertion. The
absence of labeling with DOPC vesicles further demonstrates
that the probe is restricted to the membrane. Importantly,
labeling occurred irrespective of whether the probe was
attached to a PC or PG molecule, implying that there is no
large scale enrichment of acidic phospholipids in the
periphery of the lipid-bound SecA.
SecA interacts in a nucleotide-dependent manner with
model membranes containing negatively charged phospho-
lipids (34, 35, 51). However, no nucleotide dependency of
labeling with [125I]TID-PC was observed under similar
conditions. The nucleotide-dependent aggregation of vesicles
is mediated by two distinct lipid-binding sites on SecA. One
is located at the positively charged extreme C-terminus and
is involved primarily in electrostatic interactions with the
lipids. The other is located in the N-terminal region and is
involved in hydrophobic interactions with the vesicles (51).
In the presence of ATP one of these interactions is lost,
resulting in the inhibition of vesicle aggregation. The
photolabeling experiments now show that in the presence
of ATP the hydrophobic interaction still exists. It can
therefore be concluded that the interaction with the C-
terminal binding site is lost. In monolayer experiments both
binding and insertion are reduced albeit to a different extent
by nucleotides (35). Because the relation between the
molecular area and surface pressure is known for DOPG
monolayers (54), it is possible to estimate the molecular area
of SecA for different lipid-bound conformations. The
molecular area in the presence of ATP is approximately 1.5
times more as compared to the situation without nucleotides
(or with nonhydrolyzable nucleotides) from 5 to 8 nm2,
respectively. ESR studies have provided insight into the
depth of insertion (34). By the use of spin-labeled lipids it
was demonstrated that the SecA penetrates into a DOPG
bilayer up to the 14th carbon atom of the acyl chain. This
penetration is strongly reduced in the presence of ATP.
Together these results show that there is a marked confor-
mational change of SecA within the bilayer upon interaction
with different nucleotides. However, these changes appar-
ently do not result in large differences in the area exposed
to the hydrophobic region.
SecA has the ability to insert into the phospholipid bilayer.
Therefore it is conceivable that SecA bound at the translocase
is inserted in the phospholipid bilayer. Alternatively, inser-
tion could occur in a proteinacious environment. To
distinguish between these two possibilities, photolabeling of
SecA was assayed in the presence of SecYEG containing
proteoliposomes under conditions where the largest fraction
of SecA was bound to the translocase. This was directly
compared to liposomes not containing the translocase. Under
the applied conditions most of the SecA was expected to be
bound to the SecYEG complex on the basis of the affinity
(kd ) 7 nM, (22)) and the efficient protection of the His-tag
from enterokinase cleavage (44). Binding to the translocase
was functional since both translocation ATPase activity and
translocation of different precursor proteins were observed.
Under these conditions the labeling efficiency of SecA from
the phospholipid acyl chain region is only 8% compared to
the vesicles not containing SecYEG. This low level of
labeling could be derived from lipid-bound SecA or might
FIGURE 7: SecA shielding from the phospholipid acyl chains does
not depend on translocation ligands. Cross-link reactions with
SecYEG proteoliposomes (10 nmol of lipid, 55 pmol of SecYEG
in the correct orientation) were performed as described in the
legends to Figure 5. ATP and proOmpA were included where
indicated. Reactions were performed in the presence of 10 mM
sodium azide or 2 mM AMP-PNP as indicated. Control reactions
were supplemented with 10 and 20 íg of SecA, respectively.
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indicate that the SecYEG-bound SecA is to a small extent
accessible from the phospholipid bilayer. The latter would
imply that binding of SecA to the SecYEG complex reduces
the contact of SecA with the acyl chains by at least 92%.
The reduction in lipid accessibility appears not to be
dependent on nucleotides and precursor protein and is neither
inhibited nor promoted by azide or AMP-PNP, compounds
that stabilize SecA in a membrane-inserted state (3, 11, 52).
This demonstrates that SecA bound at the translocase is
largely shielded from the phospholipid acyl chains.
SecA membrane insertion during precursor protein trans-
location is usually assayed as the formation of two large
protease-resistant fragments of 65 and 30 kDa that are
derived from the N-domain and C-domain, respectively (12).
In E. coli inner membrane vesicles, these fragments could
be labeled only to a minor extent by an externally added
hydrophobic membrane marker (38). It thus appears that
these SecA fragments are largely shielded from the phos-
pholipid acyl chains under the conditions that stabilize SecA
in the membrane-inserted state. However, since these
labeling studies were performed only after proteolysis of the
SecA, it is not clear whether the lack of labeling concerned
an entire molecule or if SecA fragments that were accessible
to the label were degraded by the protease. Moreover, it is
not known whether the 65- and 30-kDa fragments originate
from the same molecule or from different subunits of the
SecA dimer. The reconstitution of SecYEG together with a
photoactivatable lipid analogue, used in the present study,
provided a system in which the SecA lipid interaction could
be studied without the need of a protease resistance assay,
that is, while retaining the active state. Therefore, also
conditions that do not lead to protease-resistant fragments
could be analyzed, showing that the intact and active state
of SecA bound to SecYEG is only poorly accessible from
the lipid bilayer. Our data therefore not only correlate but
also further extend the studies obtained with E. coli
membranes. Furthermore, the low level of labeling dem-
onstrates that shielding must occur for both subunits of the
SecA dimer. In the experiments with E. coli membranes,
labeled proteolytic fragments were obtained that were not
derived from the SecYEG-bound SecA fraction but that
presumably reflected the lipid-bound SecA (38).
Negatively charged phospholipids are involved in protein
translocation (27). Since the SecA translocation ATPase
activity is dependent on acidic phospholipids (36), it is likely
that SecA during translocation interacts with negatively
charged lipids. Surprisingly, translocase-bound SecA is
largely shielded from the phospholipid acyl chains. Acidic
lipids could be bound very specifically and function as
cofactors of SecA activity. However, this is not very likely
since high levels of acidic lipids are required for obtaining
wild-type levels of translocation, while a large variety of
anionic headgroup structures are able to restore translocation
activity of PG-depleted vesicles (55). How can the effect
of the depletion of acidic lipids from the membrane on
translocation be explained? One possibility is that the
anionic lipids enhance translocation by directly interacting
with the SecYEG complex in the absence of extensive SecA
lipid interactions. The requirement of nonbilayer preferring
phospholipids at the periplasmic site of the membrane
suggests that this type of phospholipid indeed acts directly
on SecYEG (26). Acidic lipids may also be involved in
interacting with the signal sequence (31). Since one can only
study protein translocation activity in the presence of the
SecYEGA holoenzyme and a functional precursor protein,
it remains to be determined at what level these lipids exactly
act. SecA is localized in the cytosol, bound to the membrane
phospholipids and to the high-affinity binding sites consisting
of SecYEG (6). The presence of lipid-bound SecA offers
an attractive alternative explanation for the acidic lipid
requirement. Translocase-bound SecA can be replaced by
soluble SecA during translocation (11), but no significant
amount of SecA is released from the membrane during
translocation (56). The latter thus restricts cycling to the
translocase and lipid-bound SecA pools. Decreasing the
amount of acidic phospholipids in the inner membrane results
in a decrease in the amount of membrane-bound SecA, and
this is compensated by an increase of the cytosolic SecA
levels (36). Cells apparently respond to a lower lipid-bound
fraction by increasing the cytosolic amount of SecA to drive
the equilibrium to the membrane. The lipid-bound fraction
of SecA may therefore represent a critical intermediate in
translocation and, for instance, function as a translocation
cue that rapidly replaces the “unloaded” form of SecA bound
at SecYEG. Since diffusion of the lipid-bound SecA is
restricted to only two dimensions, cycling may occur with
faster rates than with the free cytosolic fraction.
The core of the eukaryotic translocon is formed by a
heterotrimeric Sec61p complex that is homologous to the
SecYEG complex (57). The Sec61p complex forms oligo-
meric channels that assemble upon interaction with ribosomes
(58). The large degree of shielding from the phospholipid
region suggests that SecA inserts in the membrane via a pro-
teinaceous channel, possibly an oligomer of SecYEG trimers.
Such a proteinaceous channel could possibly assemble upon
interaction with lipid-inserted SecA and protect the 30- and
65-kDa fragments of SecA against proteolysis or prevent
labeling from the lipid bilayer. However, recent studies have
shown that the SecYEG is highly susceptible to proteolysis
and that it is completely degraded (fragments smaller than
6 kDa) under the conditions that stabilize the SecA fragments
in a protease-resistant and lipid-inaccessible state (44). This
may suggest that the SecYEG-bound SecA is more peripher-
ally associated with the membrane, while the lipid-bound
SecA is able to insert into the membrane.
The finding that translocase-bound SecA is largely shielded
from the phospholipid acyl chains suggests that acidic
phospholipids are involved in translocation by acting on the
lipid-bound fraction of SecA. More detailed experiments
will be needed to address the role of SecA lipid insertion
during protein translocation.
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